A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR

Clinical trial NCT02681809 · TERMINATED

Trial details

NCT number: NCT02681809
Sponsor: ThromboGenics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Retinopathy Posterior Vitreous Detachment Disease Progression

Start date: 2015-12-01
Primary completion: 2019-11-18
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.